Bramlett KS - Search Results

1

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions.

Leduc AM, Trent JO, Wittliff JL, Bramlett KS, Briggs SL, Chirgadze NY, Wang Y, Burris TP, Spatola AF. Leduc AM, et al. Among authors: bramlett ks. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11273-8. doi: 10.1073/pnas.1934759100. Epub 2003 Sep 17. Proc Natl Acad Sci U S A. 2003. PMID: 13679575 Free PMC article.

2

Potent inhibitors of LXXLL-based protein-protein interactions.

Galande AK, Bramlett KS, Trent JO, Burris TP, Wittliff JL, Spatola AF. Galande AK, et al. Among authors: bramlett ks. Chembiochem. 2005 Nov;6(11):1991-8. doi: 10.1002/cbic.200500083. Chembiochem. 2005. PMID: 16222726

3

Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions.

Galande AK, Bramlett KS, Burris TP, Wittliff JL, Spatola AF. Galande AK, et al. Among authors: bramlett ks. J Pept Res. 2004 Mar;63(3):297-302. doi: 10.1111/j.1399-3011.2004.00152.x. J Pept Res. 2004. PMID: 15049842

4

Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors.

Bramlett KS, Burris TP. Bramlett KS, et al. Mol Genet Metab. 2002 Jul;76(3):225-33. doi: 10.1016/s1096-7192(02)00043-4. Mol Genet Metab. 2002. PMID: 12126937

5

Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method.

Dai SY, Chalmers MJ, Bruning J, Bramlett KS, Osborne HE, Montrose-Rafizadeh C, Barr RJ, Wang Y, Wang M, Burris TP, Dodge JA, Griffin PR. Dai SY, et al. Among authors: bramlett ks. Proc Natl Acad Sci U S A. 2008 May 20;105(20):7171-6. doi: 10.1073/pnas.0710802105. Epub 2008 May 12. Proc Natl Acad Sci U S A. 2008. PMID: 18474858 Free PMC article.

6

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

Bramlett KS, Wu Y, Burris TP. Bramlett KS, et al. Mol Endocrinol. 2001 Jun;15(6):909-22. doi: 10.1210/mend.15.6.0649. Mol Endocrinol. 2001. PMID: 11376110

7

Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs.

Ko L, Cardona GR, Iwasaki T, Bramlett KS, Burris TP, Chin WW. Ko L, et al. Among authors: bramlett ks. Mol Endocrinol. 2002 Jan;16(1):128-40. doi: 10.1210/mend.16.1.0755. Mol Endocrinol. 2002. PMID: 11773444

8

Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.

Bramlett KS, Burris TP. Bramlett KS, et al. J Steroid Biochem Mol Biol. 2003 Jul;86(1):27-34. doi: 10.1016/s0960-0760(03)00258-9. J Steroid Biochem Mol Biol. 2003. PMID: 12943742

9

Pharmacology of nuclear receptor-coregulator recognition.

Savkur RS, Bramlett KS, Clawson D, Burris TP. Savkur RS, et al. Among authors: bramlett ks. Vitam Horm. 2004;68:145-83. doi: 10.1016/S0083-6729(04)68005-8. Vitam Horm. 2004. PMID: 15193454 Review.

10

Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.

Savkur RS, Thomas JS, Bramlett KS, Gao Y, Michael LF, Burris TP. Savkur RS, et al. Among authors: bramlett ks. J Pharmacol Exp Ther. 2005 Jan;312(1):170-8. doi: 10.1124/jpet.104.072124. Epub 2004 Aug 25. J Pharmacol Exp Ther. 2005. PMID: 15329387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters